These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19787591)

  • 1. Mitomycin C aqueous humor concentration after photorefractive keratectomy: an experimental study.
    Kymionis GD; Diakonis VF; Panagopoulou SI; Grentzelos MA; Kazakos DC; Tzatzarakis MN; Tsatsakis AM; Pallikaris AI
    Eur J Ophthalmol; 2009; 19(5):738-42. PubMed ID: 19787591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of mitomycin C in rabbit corneal tissue and aqueous humor after topical administration.
    Song JS; Kim JH; Yang M; Sul D; Kim HM
    Cornea; 2006 Dec; 25(10 Suppl 1):S20-3. PubMed ID: 17001187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin-C concentration in cornea and aqueous humor and apoptosis in the stroma after topical mitomycin-C application: effects of mitomycin-C application time and concentration.
    Song JS; Kim JH; Yang M; Sul D; Kim HM
    Cornea; 2007 May; 26(4):461-7. PubMed ID: 17457196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of mitomycin-C in the anterior chamber after photorefractive keratectomy.
    Torres RM; Merayo-Lloves J; Daya SM; Blanco-Mezquita JT; Espinosa M; Nozal MJ; Bernal JL; Bernal J
    J Cataract Refract Surg; 2006 Jan; 32(1):67-71. PubMed ID: 16516781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mitomycin-C on the variance in refractive outcomes after photorefractive keratectomy.
    Sy ME; Zhang L; Yeroushalmi A; Huang D; Hamilton DR
    J Cataract Refract Surg; 2014 Dec; 40(12):1980-4. PubMed ID: 25305150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Single-Step Transepithelial Photorefractive Keratectomy With or Without Mitomycin C in Mild to Moderate Myopia.
    Adib-Moghaddam S; Soleyman-Jahi S; Tefagh G; Tofighi S; Grentzelos MA; Kymionis GD
    J Refract Surg; 2018 Jun; 34(6):400-407. PubMed ID: 29889293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C in photorefractive keratectomy: effect on epithelialization and predictability.
    Leccisotti A
    Cornea; 2008 Apr; 27(3):288-91. PubMed ID: 18362654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photorefractive keratectomy with mitomycin C versus LASIK in custom surgeries for myopia: a bilateral prospective randomized clinical trial.
    Wallau AD; Campos M
    J Refract Surg; 2008 Apr; 24(4):326-36. PubMed ID: 18500080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.
    Hofmeister EM; Bishop FM; Kaupp SE; Schallhorn SC
    J Cataract Refract Surg; 2013 Sep; 39(9):1358-65. PubMed ID: 23830559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed epithelial healing following photorefractive keratectomy with mitomycin C treatment.
    Kremer I; Ehrenberg M; Levinger S
    Acta Ophthalmol; 2012 May; 90(3):271-6. PubMed ID: 20456254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C-induced reduction of keratocytes and fibroblasts after photorefractive keratectomy.
    Kim TI; Pak JH; Lee SY; Tchah H
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2978-84. PubMed ID: 15326110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin-C in hyperopic photorefractive keratectomy.
    Leccisotti A
    J Cataract Refract Surg; 2009 Apr; 35(4):682-7. PubMed ID: 19304089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial.
    Nassiri N; Farahangiz S; Rahnavardi M; Rahmani L; Nassiri N
    J Cataract Refract Surg; 2008 Jun; 34(6):902-8. PubMed ID: 18498993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal Breakthrough Haze After Photorefractive Keratectomy With Mitomycin C: Incidence and Risk Factors.
    Kaiserman I; Sadi N; Mimouni M; Sela T; Munzer G; Levartovsky S
    Cornea; 2017 Aug; 36(8):961-966. PubMed ID: 28542088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photorefractive keratectomy with 0.02% mitomycin C for treatment of residual refractive errors after LASIK.
    Srinivasan S; Drake A; Herzig S
    J Refract Surg; 2008 Jan; 24(1):S64-7. PubMed ID: 18269153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The U.S. Army Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK in moderate to high myopia.
    Sia RK; Ryan DS; Edwards JD; Stutzman RD; Bower KS
    J Refract Surg; 2014 Apr; 30(4):256-64. PubMed ID: 24702577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of mitomycin C on tear function after photorefractive keratectomy: a contralateral comparative study.
    Farahi A; Hashemi H; Mehravaran S
    J Refract Surg; 2013 Apr; 29(4):260-4. PubMed ID: 23557224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced application time for prophylactic mitomycin C in photorefractive keratectomy.
    Virasch VV; Majmudar PA; Epstein RJ; Vaidya NS; Dennis RF
    Ophthalmology; 2010 May; 117(5):885-9. PubMed ID: 20163867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia.
    Thornton I; Xu M; Krueger RR
    J Refract Surg; 2008 Jan; 24(1):S68-76. PubMed ID: 18269154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mitomycin-C for phototherapeutic keratectomy and photorefractive keratectomy surgery.
    Shah RA; Wilson SE
    Curr Opin Ophthalmol; 2010 Jul; 21(4):269-73. PubMed ID: 20489622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.